Back to search
FDAFDA · Food and drugs·Recall number D-0224-2021

Benzhydrocodone and Acetaminophen Tablets, CII, 6.12mg/ 325mg, 100 Tablets, Rx Only, Manufactured for: KVK-Tech, Inc., Newtown, PA 18940 USA, NDC 10702-344-01

Published January 20, 2021 · Recall initiated: December 18, 2020

Summary

FDA records drug Class III recall D-0224-2021, published January 20, 2021 and initiated December 18, 2020. Recalling firm: KVK-Tech, Inc.; Status: Terminated; Reported quantity: 528 bottles; Lot: Batch# 15892A, Exp, 2021-FEB. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications; out of specification results obtained for N-Oxide impurity during the 12-month long term stability testing for Batch# 15892A

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
KVK-Tech, Inc.
Distributor
Nationwide
Lot
Batch# 15892A, Exp, 2021-FEB
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Benzhydrocodone and Acetaminophen Tablets, CII, 6.12mg/ 325mg, 100 Tablets, Rx Only, Manufactured for: KVK-Tech, Inc., Newtown, PA 18940 USA, NDC 10702-344-01 recalled?

Yes. FDA published recall D-0224-2021 on January 20, 2021. Reported hazard: Failed Impurities/Degradation Specifications; out of specification results obtained for N-Oxide impurity during the 12-month long term stability testing for Batch# 15892A

What should I do if I have this product?

Voluntary: Firm initiated · Letter